RT Journal Article
SR Electronic
T1 Household transmissions of SARS-CoV-2 in the time of unprecedented travel lockdown in China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.02.20029868
DO 10.1101/2020.03.02.20029868
A1 Xiao-Ke Xu
A1 Xiao-Fan Liu
A1 Lin Wang
A1 Sheikh Taslim Ali
A1 Zhanwei Du
A1 Paolo Bosetti
A1 Benjamin J. Cowling
A1 Ye Wu
YR 2020
UL http://medrxiv.org/content/early/2020/03/30/2020.03.02.20029868.abstract
AB Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the city of Wuhan, China, in December 2019 and then spread globally. Limited information is available for characterizing epidemiological features and transmission patterns in the regions outside of Hubei Province. Detailed data on transmission at the individual level could be an asset to understand the transmission mechanisms and respective patterns in different settings.Objective To reconstruct infection events and transmission clusters of SARS-CoV-2 for estimating epidemiological characteristics at household and non-household settings, including super-spreading events, serial intervals, age- and gender-stratified risks of infection in China outside of Hubei Province.Design, Setting, and Participants 9,120 confirmed cases reported online by 264 Chinese urban Health Commissions in 27 provinces from January 20 to February 19, 2020. A line-list database is established with detailed information on demographic, social and epidemiological characteristics. The infection events are categorized into the household and non-household settings.Exposures Confirmed cases of SARS-CoV-2 infections.Main Outcomes and Measures Information about demographic characteristics, social relationships, travel history, timelines of potential exposure, symptom onset, confirmation, and hospitalization were extracted from online public reports. 1,407 infection events formed 643 transmission clusters were reconstructed.Results In total 34 primary cases were identified as super spreaders, and 5 household super-spreading events were observed. The mean serial interval is estimated to be 4.95 days (standard deviation: 5.24 days) and 5.19 days (standard deviation: 5.28 days) for households and non-household transmissions, respectively. The risk of being infected outside of households is higher for age groups between 18 and 64 years, whereas the hazard of being infected within households is higher for age groups of young (<18) and elderly (>65) people.Conclusions and Relevance The identification of super-spreading events, short serial intervals, and a higher risk of being infected outside of households for male people of age between 18 and 64 indicate a significant barrier to the case identification and management, which calls for intensive non-pharmaceutical interventions (e.g. cancellation of public gathering, limited access of public services) as the potential mitigation strategies.Question What epidemiological characteristics and risk factors are associated with household and non-household transmissions of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China outside of Hubei Province?Findings In this epidemiological study analyzing 1,407 SARS-CoV-2 infection events reported between 20 January 2020 and 19 February 2020, 643 transmission clusters were reconstructed to demonstrate the non-negligible frequency of super-spreading events, short duration of serial intervals, and a higher risk of being infected outside of household for male people of age between 18 and 64 years.Meaning These findings provide epidemiological features and risk estimates for both household and non-household transmissions of SARS-CoV-2 in China outside of Hubei Province.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (61773091).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be available for download after the manuscript is published on a journal.